ACYP2 Induces Temozolomide Resistance in Glioblastoma by Promoting PARP1-Mediated DNA Damage Repair
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Acylphosphatase 2 (ACYP2) drives resistance to temozolomide (TMZ) chemotherapy in glioblastoma multiforme (GBM). Targeting ACYP2 enhances TMZ efficacy by increasing DNA damage, offering a new therapeutic strategy for GBM patients.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
- Temozolomide (TMZ) is a standard chemotherapy, but resistance limits its effectiveness.
- Understanding TMZ resistance mechanisms is crucial for improving GBM treatment.
Purpose Of The Study
- To investigate the role of acylphosphatase 2 (ACYP2) in TMZ sensitivity in GBM.
- To identify ACYP2 as a potential therapeutic target for overcoming TMZ resistance.
Main Methods
- Analyzed ACYP2 expression and its effect on TMZ IC50 values in GBM cells.
- Evaluated the combined effect of ACYP2 knockdown and TMZ in vitro and in vivo.
- Assessed TMZ-induced DNA damage using comet tail and γ-H2AX assays.
- Investigated the molecular mechanism involving c-Myc and PARP1.
Main Results
- ACYP2 knockdown decreased TMZ IC50, while overexpression increased it.
- Combined ACYP2 knockdown and TMZ inhibited GBM cell malignancy and intracranial tumor progression.
- ACYP2 knockdown enhanced TMZ-induced DNA damage.
- ACYP2 upregulates c-Myc, promoting PARP1 transcription and inducing TMZ resistance.
Conclusions
- ACYP2 plays a key role in regulating TMZ sensitivity in GBM.
- The ACYP2-driven c-Myc/PARP1 axis is a critical pathway for TMZ resistance.
- ACYP2 is a potential therapeutic target for TMZ-resistant GBM.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...